# Ceri Hirst

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/ceri-hirst/

## Facts

| Field | Value |
| --- | --- |
| Citations | 955 |
| Field | Hemophilia Treatment and Research |
| h-index | 18 |
| i10-index | 21 |
| Last Known Institution | Novartis (United Kingdom) |
| OpenAlex ID | https://openalex.org/A5033914499 |
| ORCID iD | 0000-0001-9094-2437 |
| Works | 44 |

## Researcher papers

- [Nonadherence or Nonpersistence to Intravitreal Injection Therapy for Neovascular Age-Related Macular Degeneration](https://scholariq.org/papers/nonadherence-or-nonpersistence-to-intravitreal-injection-therapy-for-neovascular/)
- [Pneumococcal vaccines for sickle cell disease](https://scholariq.org/papers/pneumococcal-vaccines-for-sickle-cell-disease/)
- [Relationship between effects on time-to-disease progression and overall survival in studies of metastatic breast cancer](https://scholariq.org/papers/relationship-between-effects-on-time-to-disease-progression-and-overall-survival/)
- [Preoperative blood transfusions for sickle cell disease](https://scholariq.org/papers/preoperative-blood-transfusions-for-sickle-cell-disease/)
- [Epidemiology of castration resistant prostate cancer: A longitudinal analysis using a UK primary care database](https://scholariq.org/papers/epidemiology-of-castration-resistant-prostate-cancer-a-longitudinal-analysis/)
- [Selecting Patients with Ovarian Cancer for Germline BRCA Mutation Testing: Findings from Guidelines and a Systematic Literature Review](https://scholariq.org/papers/selecting-patients-with-ovarian-cancer-for-germline-brca-mutation-testing/)
- [Prophylactic antibiotics for preventing pneumococcal infection in children with sickle cell disease](https://scholariq.org/papers/prophylactic-antibiotics-for-preventing-pneumococcal-infection-in-children-with/)
- [Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial](https://scholariq.org/papers/empagliflozin-in-patients-admitted-to-hospital-with-covid-19-recovery-a/)
- [Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial](https://scholariq.org/papers/immunomodulatory-therapy-in-children-with-paediatric-inflammatory-multisystem/)
- [Prophylactic antibiotics for preventing pneumococcal infection in children with sickle cell disease](https://scholariq.org/papers/prophylactic-antibiotics-for-preventing-pneumococcal-infection-in-children-with-2/)
- [Health Care Resource Utilization and Productivity Impairment in Adults with Immunoglobulin A Nephropathy: A Real-World, Observational, Global Analysis](https://scholariq.org/papers/health-care-resource-utilization-and-productivity-impairment-in-adults-with/)

## Researcher topics

- [Hemophilia Treatment and Research](https://scholariq.org/topics/hemophilia-treatment-and-research/)
- [COVID-19 Clinical Research Studies](https://scholariq.org/topics/covid-19-clinical-research-studies/)
- [BRCA gene mutations in cancer](https://scholariq.org/topics/brca-gene-mutations-in-cancer/)
- [Ovarian cancer diagnosis and treatment](https://scholariq.org/topics/ovarian-cancer-diagnosis-and-treatment/)
- [Hemoglobinopathies and Related Disorders](https://scholariq.org/topics/hemoglobinopathies-and-related-disorders/)

## Researcher university

- [Novartis (United Kingdom)](https://scholariq.org/institutions/novartis-united-kingdom/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.